Microvision, Inc.
Ticker: MVIS 2203 Airport Way, Suite 100
Exchange: NASDAQ-National Market Seattle, Washington
Industry: High-Tech (206) 623-7055

Type of Shares:Common Shares Filing Date:7/15/96
U.S. Shares:2,250,000 Offer Date:8/27/96
Non-U.S. Shares:0 Filing Range:$8.00 - $10.00
Primary Shares:2,250,000 Offer Price:$8.00
Secondary Shares:0 Gross Spread:$0.61
Offering Amount: $20,250,000 Selling:$0.32
Expenses:$1,065,000 Reallowance:$0.10
Shares Out After:5,461,546

ManagerTierPhone
Paulson Investment Company, Inc.Lead Manager (503) 243-6000
Marion Bass Securities CorporationCo-manager (800) 241-9021

Audited
Income
Latest
Unaudited
Income
Prior
Unaudited
Income
Balance
Sheet
12/31/95 3/31/96 3/31/95 3/31/96
Revenue:$0.03$0.03$0.00Assets:$0.70
Net Income:-$2.94-$0.62-$0.53Liabilities:$0.58
EPS:-$0.62-$0.13-$0.11Equity:$0.11

Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year,
unaudited figures are partial year

Business Description
The company is developing information display technologies that allow electronically generated images and information to be projected directly onto the retina of the viewer's eye. The company has developed prototype virtual retinal display devices, including a hand-held monochrome version and a table top, full-color version, and is currently refining and developing its VRD technology for commercial applications. The company expects to commercialize its technology through the development of products and as a supplier of personal display technology to original equipment manufacturers. The company believes the VRD technology will be useful in a variety of applications, including portable communication devices, visual simulation and entertainment displays and devices that superimpose images on the user's field of vision. The company expects that its technology will permit the use of highly miniaturized, light weight, battery-operated, viewing devices that can be comfortably held or worn as "headphones for the eyes."

Use of Proceeds
The proceeds from the proposed offering will be used primarily for research and product development, including payments to be paid under a licensing agreement, purchase and installation of certain laboratory equipment and facilities, repayment of up to $750,000 of the company's 7% Convertible Subordinated Notes due 1997 unless converted, and for working capital.

Last updated: 10/28/96

©1996 IPO Data Systems, Inc. - All rights reserved.